Area 1: Neurological Sciences
This area covers different research topics concerning the study and treatment of brain damage.
Some studies aim at the fine clinical characterization and treatment of cognitive deficits in patients with focal brain damage due to stroke or following neurosurgery. For example, memory or language disorders (amnesia or aphasia), in their different clinical expressions, are treated experimentally after an accurate clinical evaluation through a neuro-modulation technique that uses transcranial direct continuous current stimulation (tDCS). We also perform pharmacological trials with patients suffering from neurodegenerative diseases (e.g., Alzheimer’s, ALS, …) or neuromuscular diseases (e.g., chronic inflammatory demyelinating polyneuropathy).
CCPP’s Lab of Neurobiology for Translational Medicine carries out research focused on evaluating the molecular mechanisms underlying cerebrovascular and neurodegenerative diseases, with particular attention to the discovery of potential diagnostic and / or prognostic biomarkers. This type of studies is leveraged by the CCPP BioBank, where biological samples are collected from individuals affected by various neurological diseases as well as from healthy subjects.
Area 2: Neurorehabilitation Sciences
Research on neurorehabilitation plays an important role among our scientific activities. Studies range from the application of innovative rehabilitation protocols to the use of new technologies and brain modulation. We started some retrospective studies based on the data we collected in the past few years and aiming to analyze the effectiveness variability of motor rehabilitation treatments, in patients with different cognitive deficits, and to thereon optimize the patient management multidisciplinary strategies.
Area 3: Quality of Life
Over the last few years, research studies have also concerned the improvement of patients’ quality of life, throughout the clinic-to-home continuum of care. Such studies are especially focused on improving home-based care through assistive technologies (such as sensors, artificial intelligence and robotics).
Scientific Director: dott. Massimo Corbo, Neurologist.